KIT and acute myeloid leukemia: MS typically exhibits a diffuse infiltrate of blast cells with a high nucleus-to-cytoplasmic ratio and expresses markers that are associated with AML, such as CD68, MPO, CD34, CD43, CD117, CD56, CD30, and CD99 [12,13].